Item 9.01. Financial Statements and Exhibits

(a) Financial Statements of businesses acquired





MVE Cryobiological Business

The financial statements of the MVE cryobiological business are attached as Exhibit 99.2 and Exhibit 99.4 and are incorporated herein by reference.





CRYOPDP

The financial statements of CRYOPDP are attached as Exhibit 99.3 and Exhibit 99.5 and are incorporated herein by reference.

(b) Pro forma financial information

The unaudited pro forma condensed combined financial information for the Company, the MVE cryobiological business and CRYOPDP is attached hereto as Exhibit 99.1 and is incorporated herein by reference. This unaudited pro forma condensed combined financial information may not be indicative of what our actual financial position or results of operations would have been if the Transactions had been consummated on such dates and are not necessarily indicative of results to be expected for any future period following the Transactions.





(d) Exhibits

The exhibits filed as part of this Current Report on Form 8-K are listed in the index to exhibits immediately preceding the signature page to this Current Report on Form 8-K, which index to exhibits is incorporated herein by reference.





Exhibit No.                                Description
  23.1          Consent of Deloitte & Touche LLP.
  23.2          Consent of Crowe HAF.
  99.1          The unaudited pro forma condensed combined financial information for
              the Company, the MVE cryobiological business and CRYOPDP as of and for
              the nine months ended September 30, 2020 and for the year ended
              December 31, 2019 and the related notes.
  99.2          The audited combined financial statements of the MVE cryobiological
              business for the years ended December 31, 2018 and December 31, 2019
              and the related notes.
  99.3          The audited consolidated financial statements of the CRYOPDP for the
              years ended December 31, 2018 and December 31, 2019 and the related
              notes.
  99.4          The unaudited condensed combined financial statements of the MVE
              cryobiological business as of December 31, 2019 and September 30, 2020
              and for the nine months ended September 30, 2019 and 2020 and the
              related notes.
  99.5          The unaudited consolidated financial statements of CRYOPDP as of
              December 31, 2019 and September 30, 2020 and for the nine months ended
              September 30, 2019 and 2020 and the related notes.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 14, 2020 Cryoport, Inc.



                        /s/ Robert Stefanovich
                        Robert Stefanovich
                        Chief Financial Officer

© Edgar Online, source Glimpses